Skip to main content
. 2021 May 18;6:100127. doi: 10.1016/j.lanepe.2021.100127

Fig. 4.

Fig. 4

Log normalised antibody titres for anti-Spike, anti-Receptor Binding Domain and anti-Nucleocapsid. Each panel is stratified by reporting of COVID-19-like symptoms by the participant. The shape shows the density of the distribution of samples.